65,437 trials
Conduct Disorder
Primary: The Primary Outcome Efficacy Measure: Rating of Aggression Against People and/or Property Scale (RAAPP) (Kemph et al 1993) — 1.7 units on a scale
Hepatitis C Virus · Advanced Fibrosis · Cirrhosis
Primary: Determination of the Effect of PEG-Intron 0.5mg Per kg Weekly sc Versus Colchicine 0.6mg Bid Daily on: — 53; 59 Participants
Cardiovascular Disease · Oxidative Stress
Primary: LDL Cholesterol — 0.9; -12.6; -0.4; -18.5 mg/dL
Arthralgia · Musculoskeletal Complications · Pain
Primary: Number of Early Breast Cancer Patients Prescribed Adjuvant Letrozole That Are Vitamin D Deficient and Who Experience Myalgias, Arthralgias and/or Joint Stiffness — 12; 1…
Sleep Apnea, Central · Sleep Disordered Breathing · Heart Failure
Primary: The Proportion of Participants Experiencing a Reduction in Apnea-hypopnea Index (AHI) — 35; 8 Participants — p=<0.0001
Muscle Damage
Primary: Maximal Voluntary Contraction (MVC) — 182.4; 198.7; 208; 186.4 Newton-meters
Atrophy of Edentulous Alveolar Ridge
Primary: Alveolar Ridge Volumetric Changes — -8.36; -15.83 percentage of volume change
Type 2 Diabetes · Hypoglycemia
Primary: Glycemic Variability Measured by Mean Amplitude of Glucose Excursions (MAGE) — 6.68; 6.23 mg/dL — p=0.4510
Chronic Obstructive Pulmonary Disease
Primary: Trough Forced Expiratory Volume in 1 Second (FEV1) at 12 Weeks — 1.76; 1.86 Liters — p=0.262
Tardive Dyskinesia
Primary: Abnormal Involuntary Movement Scale (AIMS) Dyskinesia Total Score Change From Baseline at Week 6 — -0.1; -3.2; -1.9 scores on a scale — p=<0.0001
Respiratory Syncytial Virus Infections
Primary: Number of Subjects With Abnormal Biochemical Laboratory Values. — 0; 0; 48; 50 Participants
Urinary Incontinence
Primary: Incontinent Episodes Per Day — 7.34; 3.90 incontinence episodes per day — p=<0.01
Cachexia · Non-Small Cell Lung Cancer
Primary: Change in Lean Body Mass — 0.65; -0.98 kg — p=< 0.0001
Cocaine Dependence
Primary: Proportion of Cocaine Positive Urine Samples Per Treatment Condition — 45.4; 42.7; 53.5; 46.5 percentage of positive urine samples — p=0.531
Oromandibular Dystonia · Cranial Dystonia
Primary: Percent Change of the Sum of the Eyes, Mouth, Speech and Swallowing Subscores of the Burke-Fahn-Marsden (BFM) Dystonia Scale. — 12.16; 31.25 percent change